Classic cytotoxic drugs: a narrow path for regulatory approval

Affiliation auteursAffiliation ok
TitreClassic cytotoxic drugs: a narrow path for regulatory approval
Type de publicationJournal Article
Year of Publication2017
AuteursPivot X
JournalLANCET ONCOLOGY
Volume18
Pagination279-281
Date PublishedMAR
Type of ArticleEditorial Material
ISSN1470-2045
DOI10.1016/S1470-2045(17)30089-X